Consensus Collegium Pharmaceutical, Inc.

Equities

COLL

US19459J1043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
36.42 ^USD	+1.62%		+4.54%	+18.32%

Apr. 11	Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes	MT
Feb. 26	Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	MT

Evolution of the average Target Price on Collegium Pharmaceutical, Inc.

Price target over the last 5 years

History of analyst recommendation changes

06e368ff98150fc1af30.8wh0bQjoJ2Om6zUVR18ZJZl3SAdPsEw_o3oA46_wc_0.wW0fQG6dTzHcinYjEi5Ia9MeJmMB8iJ85BZWmeypXorAeSJZWqxNCfeEWg~e9462d64181fc846912c71509deb16e4

Analyst Recommendations on Collegium Pharmaceutical, Inc.

Piper Sandler Adjusts Price Target on Collegium Pharmaceutical to $39 From $37, Maintains Overweight Rating	Feb. 26	MT
Truist Adjusts Price Target on Collegium Pharmaceutical to $40 From $37, Maintains Buy Rating	Feb. 26	MT
Truist Adjusts Collegium Pharmaceutical's Price Target to $37 From $31, Keeps Buy Rating	Jan. 04	MT
Jefferies Downgrades Collegium Pharmaceutical to Hold From Buy, Raises Price Target to $37 From $30	Jan. 04	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $36 From $35, Maintains Buy Rating	23-08-25	MT
Jefferies Assumes Collegium Pharmaceutical at Buy With $30 Price Target	23-05-02	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $35 From $34, Maintains Buy Rating	23-01-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $34 From $36, Maintains Buy Rating	22-11-04	MT
HC Wainwright Downgrades Collegium Pharmaceutical to Neutral From Buy	22-08-08	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $36 From $34, Keeps Buy Rating	22-04-06	MT
Piper Sandler Adjusts Collegium Pharmaceutical's Price Target to $42 From $36, Reiterates Overweight Rating	22-02-22	MT
Needham Adjusts Collegium Pharmaceutical's Price Target to $34 From $28, Reiterates Buy Rating	22-02-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 From $26, Reiterates Buy Rating	22-02-15	MT
Cantor Fitzgerald Upgrades Collegium Pharmaceutical to Overweight From Neutral; Price Target is $26	22-02-15	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rating	21-11-15	MT
HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating	21-11-05	MT
Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy Rating	21-11-05	MT
COLLEGIUM PHARMACEUTICAL : Cantor Fitzgerald Downgrades Collegium Pharmaceutical to Neutral from Overweight, Adjusts Price Target to $22 from $30	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $28 From $33, Maintains Buy Rating	21-08-06	MT
COLLEGIUM PHARMACEUTICAL : HC Wainwright Adjusts Collegium Pharmaceutical's Price Target to $29 from $31, Maintains Buy Rating	20-11-09	MT